Summary & Overview
HCPCS Level II M1375: Additional Rheumatoid Arthritis Encounter
HCPCS Level II code M1375 designates an additional encounter for patients with a rheumatoid arthritis (RA) diagnosis that occurs at least 90 days before or after another RA encounter within the performance period. Nationally, this code captures discrete RA-related encounters used in performance measurement and care continuity tracking. It is relevant for clinicians, coders, and payers focused on chronic disease management and quality reporting.
Key payers in scope include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what M1375 represents, typical service settings, and the role the code plays in measuring repeat or interval RA encounters. The publication outlines expected use cases, reporting context, and where to look for associated guidance. Any missing specifics such as associated taxonomies or linked ICD-10 diagnoses are noted as unavailable in the input.
This brief provides operational clarity for billing and coding teams handling RA follow-up encounters, and serves as a reference for payer contract reviewers and quality measurement leads assessing encounter-based RA metrics.
Billing Code Overview
HCPCS Level II code M1375 indicates an additional encounter with a rheumatoid arthritis (RA) diagnosis during the performance period or prior performance period that occurs at least 90 days before or after an encounter with an RA diagnosis during the performance period. The service represents an episodic follow-up or separate encounter tied to rheumatoid arthritis management.
-
Service type: Ambulatory office or outpatient encounter for rheumatoid arthritis follow-up or assessment
-
Typical site of service: Physician office, outpatient clinic, or ambulatory care setting
Clinical & Coding Specifications
Clinical Context
A typical patient is a 58-year-old individual with a documented diagnosis of rheumatoid arthritis who presents for outpatient follow-up visits over a performance period for quality measurement or registry reporting. The billing code M1375 is used to indicate an additional encounter with an RA diagnosis that occurs at least 90 days before or after a documented encounter with an RA diagnosis during the performance period. The clinical workflow begins with a scheduling or triage contact, in-person or telehealth evaluation by a rheumatology clinician or primary care provider, medication reconciliation, symptom assessment (joint pain, swelling, morning stiffness), review of disease activity measures (for example, CDAI or RAPID3), and documentation of diagnosis and encounter dates. Laboratory testing (for example, inflammatory markers, medication safety labs) or imaging may be ordered as clinically indicated. The encounter is coded with the primary visit CPT or E/M code appropriate to the visit and M1375 is appended when the visit meets the timing and diagnostic criteria described by the code to support registry or performance reporting. Typical sites of service include outpatient clinic, physician office, rheumatology specialty clinic, and telehealth/virtual visit platforms. Common patient scenario: a patient with stable rheumatoid arthritis seen for medication follow-up 120 days after a prior RA visit; the clinician documents the RA diagnosis and relevant assessment, and M1375 is reported to indicate the additional qualifying encounter relative to the performance period.
Coding Specifications
| Modifier |
|---|